Research
Hormonal
The gut is a promising target for therapeutic interventions to achieve significant weight loss.
Practitioners should consider gut-targeted therapies as viable options for obesity treatment.
StrongSupportsmedium confidence
The effectiveness of these approaches shows that that the gut is a promising target for therapeutic interventions to achieve significant weigh loss.
Why this rating
The claim is supported by the effectiveness of current therapies mentioned in the abstract.
Source
Targeting the Gut in Obesity: Signals from the Inner Surface
Natalia Petersen et al. · Metabolites · 2022
DOI 10.3390/metabo12010039
reviewCited 8×
Read the paper DOI resolved against Crossref · corpus check 2026-06-10
More from this paper
Related findings · Hormonal
- Initial treatment for type 2 diabetes should be a combination of metformin and either an SGLT-2 inhibitor or a GLP-1 receptor agonist to achieve cardiorenal protection, rather than monotherapy or older agents like sulfonylureas.Strong
- For patients with specific monogenic obesity syndromes (leptin deficiency, POMC/PCSK1/LEPR mutations), targeted pharmacotherapy (recombinant leptin or setmelanotide) is highly effective and should be prioritized, unlike in polygenic obesity.Strong
- Continued weekly administration of 2.4 mg subcutaneous semaglutide prevents weight regain and promotes further weight loss in adults with overweight or obesity, whereas switching to placebo results in significant weight regain.Strong
This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →